209 related articles for article (PubMed ID: 26776226)
1. MmpL3 Inhibitors: Diverse Chemical Scaffolds Inhibit the Same Target.
Poce G; Consalvi S; Biava M
Mini Rev Med Chem; 2016; 16(16):1274-1283. PubMed ID: 26776226
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis.
Li W; Upadhyay A; Fontes FL; North EJ; Wang Y; Crans DC; Grzegorzewicz AE; Jones V; Franzblau SG; Lee RE; Crick DC; Jackson M
Antimicrob Agents Chemother; 2014 Nov; 58(11):6413-23. PubMed ID: 25136022
[TBL] [Abstract][Full Text] [Related]
3. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
[TBL] [Abstract][Full Text] [Related]
4. MmpL3 inhibitors as antituberculosis drugs.
Shao M; McNeil M; Cook GM; Lu X
Eur J Med Chem; 2020 Aug; 200():112390. PubMed ID: 32447196
[TBL] [Abstract][Full Text] [Related]
5. A piperidinol-containing molecule is active against
Dupont C; Chen Y; Xu Z; Roquet-Banères F; Blaise M; Witt AK; Dubar F; Biot C; Guérardel Y; Maurer FP; Chng SS; Kremer L
J Biol Chem; 2019 Nov; 294(46):17512-17523. PubMed ID: 31562241
[No Abstract] [Full Text] [Related]
6. HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter.
Zheng H; Williams JT; Coulson GB; Haiderer ER; Abramovitch RB
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661875
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.
Li W; Obregón-Henao A; Wallach JB; North EJ; Lee RE; Gonzalez-Juarrero M; Schnappinger D; Jackson M
Antimicrob Agents Chemother; 2016 Sep; 60(9):5198-207. PubMed ID: 27297488
[TBL] [Abstract][Full Text] [Related]
8. Targeting MmpL3 for anti-tuberculosis drug development.
Bolla JR
Biochem Soc Trans; 2020 Aug; 48(4):1463-1472. PubMed ID: 32662825
[TBL] [Abstract][Full Text] [Related]
9. 1
Korycka-Machała M; Viljoen A; Pawełczyk J; Borówka P; Dziadek B; Gobis K; Brzostek A; Kawka M; Blaise M; Strapagiel D; Kremer L; Dziadek J
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332069
[TBL] [Abstract][Full Text] [Related]
10. Altered drug efflux under iron deprivation unveils abrogated MmpL3 driven mycolic acid transport and fluidity in mycobacteria.
Pal R; Hameed S; Fatima Z
Biometals; 2019 Feb; 32(1):49-63. PubMed ID: 30430296
[TBL] [Abstract][Full Text] [Related]
11. Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors.
McNeil MB; O'Malley T; Dennison D; Shelton CD; Sunde B; Parish T
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055263
[TBL] [Abstract][Full Text] [Related]
12. Direct Inhibition of MmpL3 by Novel Antitubercular Compounds.
Li W; Stevens CM; Pandya AN; Darzynkiewicz Z; Bhattarai P; Tong W; Gonzalez-Juarrero M; North EJ; Zgurskaya HI; Jackson M
ACS Infect Dis; 2019 Jun; 5(6):1001-1012. PubMed ID: 30882198
[TBL] [Abstract][Full Text] [Related]
13. Structure-Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis.
Belardinelli JM; Yazidi A; Yang L; Fabre L; Li W; Jacques B; Angala SK; Rouiller I; Zgurskaya HI; Sygusch J; Jackson M
ACS Infect Dis; 2016 Oct; 2(10):702-713. PubMed ID: 27737557
[TBL] [Abstract][Full Text] [Related]
14. Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in
Grover S; Engelhart CA; Pérez-Herrán E; Li W; Abrahams KA; Papavinasasundaram K; Bean JM; Sassetti CM; Mendoza-Losana A; Besra GS; Jackson M; Schnappinger D
ACS Infect Dis; 2021 Jan; 7(1):141-152. PubMed ID: 33319550
[TBL] [Abstract][Full Text] [Related]
15. Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria.
Fay A; Czudnochowski N; Rock JM; Johnson JR; Krogan NJ; Rosenberg O; Glickman MS
mBio; 2019 Jun; 10(3):. PubMed ID: 31239378
[TBL] [Abstract][Full Text] [Related]
16. MmpL3 a potential new target for development of novel anti-tuberculosis drugs.
Rayasam GV
Expert Opin Ther Targets; 2014 Mar; 18(3):247-56. PubMed ID: 24325728
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterial Membrane Protein Large 3 (MmpL3) Inhibitors: A Promising Approach to Combat Tuberculosis.
Umare MD; Khedekar PB; Chikhale RV
ChemMedChem; 2021 Oct; 16(20):3136-3148. PubMed ID: 34288519
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of anti-mycobacterial drug leads that target the mycolic acid transporter MmpL3.
Hu T; Yang X; Liu F; Sun S; Xiong Z; Liang J; Yang X; Wang H; Yang X; Guddat LW; Yang H; Rao Z; Zhang B
Structure; 2022 Oct; 30(10):1395-1402.e4. PubMed ID: 35981536
[TBL] [Abstract][Full Text] [Related]
19. Molecular Modelling and Atomistic Insights into the Binding Mechanism of MmpL3 Mtb.
Kwofie SK; Hanson G; Sasu H; Enninful KS; Mensah FA; Nortey RT; Yeboah OP; Agoni C; Wilson MD
Chem Biodivers; 2022 Sep; 19(9):e202200160. PubMed ID: 35969844
[TBL] [Abstract][Full Text] [Related]
20. Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in
Raynaud C; Daher W; Johansen MD; Roquet-Banères F; Blaise M; Onajole OK; Kozikowski AP; Herrmann JL; Dziadek J; Gobis K; Kremer L
ACS Infect Dis; 2020 Feb; 6(2):324-337. PubMed ID: 31860799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]